On-X trial could expand valve's use
This article was originally published in Clinica
Executive Summary
Austin, Texas-based On-X Life Technologies has completed enrolment in the high-risk aortic valve replacement patient group in a trial of its mechanical heart valve. If the trial is successful, the On-X valve may become the only mechanical heart valve that does not require recipients to take large quantities of anticoagulant medication.